Seelos Therapeutics
SEEL
#10593
Rank
S$0.27 M
Marketcap
S$0.47
Share price
-31.49%
Change (1 day)
-98.21%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): S$6.01 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$47.73 Million, an increase over its 2022 earnings that were of -S$92.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$6.01 M-112.59%
2023 -S$47.73 Million-48.58%
2022 -S$92.82 Million14.07%
2021 -S$81.37 Million240.34%
2020 -S$23.91 Million-62.76%
2019 -S$64.2 Million587.73%
2018 -S$9.34 Million-36.54%
2017 -S$14.71 Million74.83%
2016 -S$8.42 Million-63.26%
2015 -S$22.9 Million-18.06%
2014 -S$27.95 Million46.19%
2013 -S$19.12 Million-31.67%
2012 -S$27.98 Million
2010 -S$26.21 Million448.63%
2009 -S$4.78 Million-25.83%
2008 -S$6.45 Million-45.65%
2007 -S$11.85 Million2.82%
2006 -S$11.53 Million-41.86%
2005 -S$19.83 Million-9.27%
2004 -S$21.85 Million114.92%
2003 -S$10.17 Million-70.78%
2002 -S$34.8 Million60.2%
2001 -S$21.72 Million70.3%
2000 -S$12.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.19 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA